Anfield Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Anfield Capital Management, LLC

  • $255 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023
SELL
$62.39 - $113.8 $77,488 - $141,339
-1,242 Reduced 63.79%
705 $80,000
Q3 2022

Nov 09, 2022
BUY
$58.92 - $84.67 $3,535 - $5,080
60 Added 3.18%
1,947 $120,000
Q2 2022

Aug 09, 2022
BUY
$79.4 - $116.36 $35,333 - $51,780
445 Added 30.86%
1,887 $151,000
Q1 2022

May 13, 2022
BUY
$86.42 - $109.81 $124,617 - $158,346
1,442 New
1,442 $152,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Anfield Capital Management, LLC Portfolio

Follow Anfield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anfield Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email